CIK 0001850270 · <br>Emerging growth company
PROKIDNEY CORP.
Sign in to watch- Ticker
- PROK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- EIN
- 981586514
- Phone
- 336-999-7028
- Business address
- 2000 FRONTIS PLAZA BLVD., SUITE 250, WINSTON-SALEM, NC, 27103
- Former names
- Social Capital Suvretta Holdings Corp. III
- 424B5 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 8-K Event Results of operations · Regulation FD disclosure · Other events
- 4 Derivatives Options or other derivatives
- 4 Conversion Chief Regulatory Officer acquired 200,000 shares (conversion)
- 8-K Event Material agreement
- S-3 Offering Registration Statement
- 4 Open-market sale Director sold 757,164 shares at an average $1.41 ($1,067,773)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Conversion Director acquired 757,164 shares (conversion)
- 4 Derivatives Options or other derivatives
- 4 Conversion Chief Legal Officer acquired 163,857 shares (conversion)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 1 of 21 · 404 filings